human
rhinovirus
rv
virus
belong
genu
enteroviru
famili
picornavirida
first
rv
discov
approxim
rv
serotyp
classifi
speci
earli
develop
molecular
diagnost
techniqu
group
identifi
rv
genom
consist
structur
nonstructur
region
flank
region
utr
recent
genotyp
classif
rv
propos
accord
sequenc
rv
classifi
speci
http
wwwpicornaviridaecom
rv
caus
respiratori
ill
throughout
world
throughout
studi
use
molecular
method
viral
cultur
demonstr
rv
common
caus
upper
respiratori
tract
thought
caus
rel
mild
upper
respiratori
tract
ill
rv
suggest
link
exacerb
chronic
pulmonari
diseas
includ
chronic
obstruct
pulmonari
rv
reportedli
detect
infant
children
sever
well
elderli
patient
fatal
recent
nucleic
acid
amplif
techniqu
becom
major
tool
diagnosi
viral
infect
mani
revers
transcript
polymeras
chain
reaction
assay
detect
rv
describ
gener
sensit
quantit
result
laboratori
diagnost
howev
method
requir
multipl
step
highli
special
technic
skill
take
time
gener
result
hour
isotherm
amplif
lamp
first
report
earli
isotherm
nucleic
acid
amplif
method
lamp
assay
perform
simpli
without
need
instrument
detect
viral
genom
within
lamp
assay
perform
use
fluoresc
dye
monitor
judgment
nake
fluoresc
dye
major
limit
bind
nonspecif
dna
lead
erron
previous
fluoresc
establish
detect
viral
rna
use
quench
primer
qprimer
quench
probe
qprobe
use
qprimer
qprobe
nonspecif
reaction
decreas
target
detect
studi
two
assay
develop
detect
rv
fluoresc
method
compet
assay
compar
assay
detect
rv
infect
use
clinic
specimen
virus
shown
tabl
isol
clinic
specimen
human
coxsackieviru
human
enteroviru
enteroviru
obtain
american
type
cultur
collect
manassa
va
nasopharyng
swab
nasal
aspir
patient
enrol
clinic
studi
approv
ethic
committe
nation
institut
infecti
diseas
showa
gener
hospit
ishimemori
nakano
children
hospit
screen
posit
rv
andor
respiratori
virus
use
studi
studi
perform
complianc
declar
helsinki
inform
consent
obtain
patient
total
nasopharyng
swab
nasal
aspir
consist
sampl
posit
rv
influenza
subtyp
viru
influenza
subtyp
viru
influenza
b
viru
respiratori
syncyti
viru
respiratori
syncyti
viru
b
human
metapneumoviru
human
parainfluenza
viru
type
human
parainfluenza
viru
type
human
coronaviru
respect
sampl
neg
viru
test
use
total
rna
prepar
clinic
specimen
isol
virus
use
magmax
viral
isol
kit
thermo
fisher
scientif
waltham
use
clinic
specimen
isol
virus
elut
kingfish
flex
thermo
fisher
scientif
accord
manufactur
instruct
purifi
viral
rna
clinic
specimen
use
random
hexam
primer
promega
madison
wi
superscript
iii
revers
transcriptas
thermo
fisher
scientif
accord
manufactur
instruct
complementari
dna
amplifi
three
separ
pcr
use
rv
speci
primer
set
tabl
phusion
dna
polymeras
new
england
biolab
ipswich
follow
pcr
cycl
condit
use
second
follow
cycl
second
second
minut
final
extens
minut
approxim
bp
amplifi
product
gel
purifi
minelut
gel
extract
kit
qiagen
hilden
germani
sequenc
perform
direct
use
amplif
primer
abi
prism
bigdy
termin
cycl
sequenc
readi
reaction
kit
version
thermo
fisher
scientif
construct
rna
control
quantifi
rna
copi
number
region
amplifi
result
pcr
product
contain
promot
transcrib
vitro
detail
procedur
describ
region
amplifi
pcr
use
phusion
dna
polymeras
new
england
biolab
pair
primer
taatacgactcactataggggtacwctrktaytmyggtamyyttgtacgcc
agwgcatckggyaayttcca
underlin
sequenc
promot
region
rna
transcrib
use
ribomax
express
larg
scale
rna
product
system
promega
treat
turbo
dnase
thermo
fisher
scientif
degrad
templat
dna
dntp
ntp
remov
use
microspin
column
ge
healthcar
piscataway
nj
follow
manufactur
instruct
transcrib
rna
quantifi
use
nanodrop
spectrophotomet
thermo
fisher
scientif
rna
concentr
use
calcul
copi
number
transcrib
rna
base
molecular
weight
avogadro
constant
integr
transcrib
rna
assess
bioanalyz
agil
technolog
santa
clara
ca
quantifi
viru
genom
carri
lightcycl
roch
basel
switzerland
describ
previous
slight
modif
use
rna
transcript
control
briefli
assay
contain
buffer
enzym
mix
primersprob
mix
water
templat
rna
use
reagent
thermo
fisher
scientif
primersprob
mix
prepar
contain
primer
probe
carri
describ
previous
slight
assay
contain
enzym
buffer
primer
templat
rna
primer
prepar
contain
primer
fip
bip
primer
lf
lb
primer
final
concentr
reaction
five
percent
one
lb
lf
primer
assay
substitut
nippon
steel
sumikin
tokyo
japan
reaction
perform
minut
use
lightcycl
roch
design
primer
set
region
rv
sequenc
use
clinic
specimen
posit
rv
sequenc
specimen
obtain
deposit
nation
center
biotechnolog
inform
access
number
two
sequenc
specimen
obtain
four
sampl
one
obtain
three
sampl
one
obtain
one
specimen
primer
set
assay
design
base
four
sequenc
set
assay
design
accord
sequenc
tabl
specif
assay
evalu
use
enterovirus
human
coxsackieviru
human
enteroviru
enteroviru
detect
data
shown
sensit
assay
evalu
use
serial
dilut
rna
purifi
sever
clinic
isol
tabl
assay
carri
independ
three
time
major
test
rv
detect
either
assay
respect
sensit
rv
differ
tabl
assay
bare
react
tabl
set
assay
detect
least
copiesreact
three
test
respect
tabl
set
assay
detect
least
copi
three
test
respect
tabl
repres
exampl
quench
signal
set
set
shown
figur
set
assay
react
major
set
assay
react
major
assay
evalu
use
rna
purifi
clinic
specimen
clinic
specimen
posit
rv
pcr
consid
singl
infect
case
either
depend
sequenc
region
describ
section
either
assay
detect
target
result
taken
posit
neither
assay
clinic
specimen
posit
influenza
subtyp
viru
influenza
subtyp
viru
influenza
b
viru
respiratori
syncyti
viru
b
human
metapneumoviru
human
parainfluenza
viru
type
human
coronaviru
clinic
specimen
neg
test
virus
consequ
shown
specif
assay
detect
rv
tabl
assay
result
clinic
specimen
posit
sequenc
show
sensit
assay
tabl
similarli
result
clinic
specimen
posit
sequenc
show
sensit
assay
tabl
neither
assay
react
three
clinic
specimen
posit
sequenc
data
shown
studi
two
assay
develop
detect
rv
use
method
primer
design
base
recent
circul
rv
japan
among
nucleic
acid
amplif
techniqu
fluoresc
perform
simpli
incub
reaction
tube
complet
within
method
nucleic
acid
amplif
nasba
detect
rv
similar
nasba
isotherm
nucleic
acid
amplif
method
perform
without
need
expens
equip
howev
nasba
take
hour
gener
result
requir
anneal
step
isotherm
amplif
step
lower
decad
sinc
nasba
assay
rv
detect
report
still
certain
whether
assay
detect
recent
circul
rv
especi
recent
identifi
recent
revers
transcript
strand
perform
isotherm
detect
rv
howev
assay
take
hour
gener
result
evalu
similar
nasba
assay
uncertain
whether
detect
rv
genom
highli
divers
differ
speci
well
within
speci
therefor
molecular
assay
typic
target
viral
genom
contain
rel
conserv
develop
assay
also
target
test
enterovirus
detect
test
speci
seven
eight
test
speci
tabl
contrast
assay
fail
detect
two
speci
tabl
may
caus
presenc
mismatch
target
rna
primer
focus
qprimer
region
four
undetect
virus
three
nucleotid
mismatch
set
qprimer
one
nucleotid
mismatch
set
qprimer
meanwhil
assay
result
show
detect
rate
test
rv
high
sensit
specif
tabl
assay
consid
use
molecular
detect
tool
rv
infect
develop
assay
sensit
detect
respect
clinic
specimen
compar
tabl
unfortun
three
clinic
specimen
avail
assay
fail
detect
cp
valu
pcr
assay
three
clinic
specimen
greater
data
shown
specul
low
concentr
viral
genom
result
nondetect
consid
inabl
assay
detect
limit
approach
evalu
use
addit
clinic
specimen
improv
assay
requir
recent
sever
molecular
epidemiolog
studi
conduct
type
rv
shown
major
circul
rv
speci
even
preval
rv
speci
differ
consid
epidemiolog
studi
sensit
develop
assay
present
studi
suggest
assay
detect
recent
circul
rv
conclus
develop
assay
perform
easili
quickli
highli
specif
detect
major
recent
circul
rv
assay
consid
help
diagnosi
rv
infect
consequ
result
help
enhanc
surveil
respiratori
ill
studi
role
rv
associ
clinic
featur
diseas
sever
author
declar
conflict
interest
